Literature DB >> 35754607

COVID-19 causing rhabdomyolysis requiring hemodialysis in a young adult.

Nitish Mittal1, Gaspar Del Rio-Pertuz2, Mostafa Abohelwa2.   

Abstract

Cases of rhabdomyolysis causing myoglobinuria in post-COVID-19 patients have been seen, and exact mechanisms behind it seem multifactorial. Some patients have severe myoglobinuria with highly elevated creatinine phosphokinase levels requiring urgent hemodialysis to keep creatinine and blood urea nitrogen levels under control and protect the kidneys from long-term damage. Here, we present a case of a 34-year-old man with a history notable for autism and hypertension who was admitted to the hospital for COVID-19 viral pneumonia and discharged without major complications. After 3 weeks, he came to the emergency room with decreased mental status and asterixis. He had red-colored urine and acute kidney injury secondary to rhabdomyolysis. His creatinine phosphokinase was 289,500 mcg/L-a level never reported before. The patient did not respond to aggressive intravenous fluids, so he was started on hemodialysis. After 1 week, he showed clinical improvement, and he was taken off dialysis in 2 weeks.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Acute kidney injury; COVID-19; rhabdomyolysis

Year:  2022        PMID: 35754607      PMCID: PMC9196726          DOI: 10.1080/08998280.2022.2051787

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  15 in total

1.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

Review 2.  Rhabdomyolysis: review of the literature.

Authors:  R Zutt; A J van der Kooi; G E Linthorst; R J A Wanders; M de Visser
Journal:  Neuromuscul Disord       Date:  2014-05-21       Impact factor: 4.296

3.  Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease.

Authors:  Kulachanya Suwanwongse; Nehad Shabarek
Journal:  Cureus       Date:  2020-04-06

4.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

6.  Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.

Authors:  Ashish Sharma; Pragya Jaiswal; Yasameen Kerakhan; Lakshmi Saravanan; Zeba Murtaza; Azka Zergham; Nagaraj-Sanchitha Honganur; Aelia Akbar; Aran Deol; Benedict Francis; Shakumar Patel; Deep Mehta; Richa Jaiswal; Jagmeet Singh; Urvish Patel; Preeti Malik
Journal:  Ann Hepatol       Date:  2020-10-16       Impact factor: 2.400

7.  ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients.

Authors:  Caibin Fan; Wei Lu; Kai Li; Yanhong Ding; Jianqing Wang
Journal:  Front Med (Lausanne)       Date:  2021-01-13

8.  COVID-19 and Rhabdomyolysis.

Authors:  Nicholas R Chedid; Swalpa Udit; Zhabiz Solhjou; Maria Y Patanwala; Alice M Sheridan; Ebrahim Barkoudah
Journal:  J Gen Intern Med       Date:  2020-07-15       Impact factor: 5.128

9.  Kidney disease is associated with in-hospital death of patients with COVID-19.

Authors:  Yichun Cheng; Ran Luo; Kun Wang; Meng Zhang; Zhixiang Wang; Lei Dong; Junhua Li; Ying Yao; Shuwang Ge; Gang Xu
Journal:  Kidney Int       Date:  2020-03-20       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.